1. Sanguinetti MC, Jurkewicz NK (1990) Two components of cardiac delayed rectifier K+ current differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195–215
2. Crumb WJ, Wible B, Arnold DJ, Payne JP, Brown AM (1995) Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 47:181–190
3. Anonymous (1997) Committee for Proprietary Medicinal Products (CPMP). Points to consider: the assessment for the potential for QT interval prolongation by non-cardiovascular medicinal products (CPMP/986/96). European Agency for the Evaluation of Medicinal Products, London
4. Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299–307
5. Anonymous (2005) ICH harmonised tripartite guideline the non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals S7B